Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial von Younes, Anas, Prof, Santoro, Armando, Prof, Shipp, Margaret, Prof, Zinzani, Pier Luigi, Prof, Timmerman, John M, MD, Ansell, Stephen, Prof, Armand, Philippe, MD, Fanale, Michelle, MD, Ratanatharathorn, Voravit, MD, Kuruvilla, John, MD, Cohen, Jonathon B, MD, Collins, Graham, MD, Savage, Kerry J, MD, Trneny, Marek, Prof, Kato, Kazunobu, MD, Farsaci, Benedetto, MD, Parker, Susan M, PhD, Rodig, Scott, MD, Roemer, Margaretha G M, MS, Ligon, Azra H, PhD, Engert, Andreas, Prof

Volltext

Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study von O'CONNOR, Owen A, PRO, Barbara, JACOBSEN, Eric, LUIGI ZINZANI, Pier, FURMAN, Richard, GOY, Andre, HAIOUN, Corinne, CRUMP, Michael, ZAIN, Jasmine M, HSI, Eric, BOYD, Adam, HORWITZ, Steven, PINTER-BROWN, Lauren, BARTLETT, Nancy, POPPLEWELL, Leslie, COIFFIER, Bertrand, JO LECHOWICZ, Mary, SAVAGE, Kerry J, SHUSTOV, Andrei R, GISSELBRECHT, Christian

Volltext

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThe... von Pfreundschuh, Michael, Prof, Kuhnt, Evelyn, MSc, Trümper, Lorenz, Prof, Österborg, Anders, Prof, Trneny, Marek, Prof, Shepherd, Lois, MD, Gill, Devinder S, MD, Walewski, Jan, MD, Pettengell, Ruth, Prof, Jaeger, Ulrich, Prof, Zinzani, Pier-Luigi, MD, Shpilberg, Ofer, Prof, Kvaloy, Stein, Prof, de Nully Brown, Peter, MD, Stahel, Rolf, MD, Milpied, Noel, Prof, López-Guillermo, Armando, MD, Poeschel, Viola, MD, Grass, Sandra, MD, Loeffler, Markus, Prof, Murawski, Niels, MD

Volltext

CD30 expression in peripheral T-cell lymphomas von Sabattini, Elena, Pizzi, Marco, Tabanelli, Valentina, Baldin, Pamela, Sacchetti, Carlo Sagramoso, Agostinelli, Claudio, Zinzani, Pier Luigi, Pileri, Stefano A

Volltext

Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma von MORSCHHAUSER, Franck, RADFORD, John, PETRINI, Mario, SEBBAN, Catherine, LUIGI ZINZANI, Pier, VAN OERS, Marinus H. J, VAN PUTTEN, Wim, BISCHOF-DELALOYE, Angelika, ROHATINER, Ama, SALLES, Gilles, KUHLMANN, Jens, HAGENBEEK, Anton, VAN HOOF, Achiel, VITOLO, Umberto, SOUBEYRAN, Pierre, TILLY, Herve, HUIJGENS, Peter C, KOLSTAD, Arne, D'AMORE, Francesco, GONZALEZ DIAZ, Marcos

Volltext

Phase II Trial of Proteasome Inhibitor Bortezomib in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma von LUIGI ZINZANI, Pier, MUSURACA, Gerardo, SABATTINI, Elena, PILERI, Stefano, BACCARANI, Michele, TANI, Monica, STEFONI, Vittorio, MARCHI, Enrica, FINA, Mariapaola, PELLEGRINI, Cinzia, ALINARI, Lapo, DERENZINI, Enrico, DE VIVO, Antonio

Volltext

Immune-related adverse events in the treatment of non-Hodgkin lymphoma with immune checkpoint inhibitors von Argnani, Lisa, Casadei, Beatrice, Pelusi, Carla, Lo Preiato, Valentina, Pagotto, Uberto, Bertoni, Francesco, Zinzani, Pier Luigi

Volltext

Diagnostic accuracy of positron emission tomography/computed tomography-driven biopsy for the diagnosis of lymphoma von Broccoli, Alessandro, Nanni, Cristina, Cappelli, Alberta, Bacci, Francesco, Gasbarrini, Alessandro, Tabacchi, Elena, Piovani, Carlo, Argnani, Lisa, Ghermandi, Riccardo, Sabattini, Elena, Golfieri, Rita, Fanti, Stefano, Zinzani, Pier Luigi

Volltext

Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma von LUIGI ZINZANI, Pier, STEFONI, Vittorio, ALINARI, Lapo, DERENZINI, Enrico, MONTINI, Giancarlo, BROCCOLI, Alessandro, BACCI, Francesco, PILERI, Stefano, BACCARANI, Michele, TANI, Monica, FANTI, Stefano, MUSURACA, Gerardo, CASTELLUCCI, Paolo, MARCHI, Enrica, FINA, Mariapaola, AMBROSINI, Valentina, PELLEGRINI, Cinzia

Volltext

Copanlisib population pharmacokinetics from phase I–III studies and exposure–response relationships in combination with rituximab von Morcos, Peter N., Moss, Jonathan, Austin, Rupert, Hiemeyer, Florian, Zinzani, Pier Luigi, Beckert, Vita, Mongay Soler, Lidia, Childs, Barrett H., Garmann, Dirk

Volltext

Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma von Zinzani, Pier Luigi, Minotti, Giorgio

Volltext

Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without ri... von Pfreundschuh, Michael, Prof, Ho, Anthony D, MD, Cavallin-Stahl, Eva, MD, Wolf, Max, Prof, Pettengell, Ruth, Prof, Vasova, Ingrid, MD, Belch, Andrew, MD, Walewski, Jan, MD, Zinzani, Pier-Luigi, MD, Mingrone, Walter, MD, Kvaloy, Stein, MD, Shpilberg, Ofer, Prof, Jaeger, Ulrich, Prof, Hansen, Mads, Prof, Corrado, Claudia, MD, Scheliga, Adriana, MD, Loeffler, Markus, Prof, Kuhnt, Evelyn, Dipl Math

Volltext

Peripheral T cell lymphomas: from the bench to the clinic von Fiore, Danilo, Cappelli, Luca Vincenzo, Broccoli, Alessandro, Zinzani, Pier Luigi, Chan, Wing C., Inghirami, Giorgio

Volltext

Consensus conference on the management of tumor lysis syndrome von Tosi, Patrizia, Barosi, Giovanni, Lazzaro, Carlo, Liso, Vincenzo, Marchetti, Monia, Morra, Enrica, Pession, Andrea, Rosti, Giovanni, Santoro, Antonio, Zinzani, Pier Luigi, Tura, Sante

Volltext

The many faces of marginal zone lymphoma von Zinzani, Pier Luigi

Volltext

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II... von Armand, Philippe, Engert, Andreas, Younes, Anas, Fanale, Michelle, Santoro, Armando, Zinzani, Pier Luigi, Timmerman, John M, Collins, Graham P, Ramchandren, Radhakrishnan, Cohen, Jonathon B, De Boer, Jan Paul, Kuruvilla, John, Savage, Kerry J, Trneny, Marek, Shipp, Margaret A, Kato, Kazunobu, Sumbul, Anne, Farsaci, Benedetto, Ansell, Stephen M

Volltext

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma von Chen, Robert, Zinzani, Pier Luigi, Fanale, Michelle A, Armand, Philippe, Johnson, Nathalie A, Brice, Pauline, Radford, John, Ribrag, Vincent, Molin, Daniel, Vassilakopoulos, Theodoros P, Tomita, Akihiro, von Tresckow, Bastian, Shipp, Margaret A, Zhang, Yinghua, Ricart, Alejandro D, Balakumaran, Arun, Moskowitz, Craig H

Volltext

Long-term analysis of phase II studies of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma von Witzig, Thomas E, Luigi Zinzani, Pier, Habermann, Thomas M, Tuscano, Joseph M, Drach, Johannes, Ramchandren, Radhakrishnan, Kalayoglu Besisik, Sevgi, Takeshita, Kenichi, Casadebaig Bravo, Marie-Laure, Zhang, Lei, Fu, Tommy, Goy, Andre

Volltext

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial von Fowler, Nathan Hale, Dickinson, Michael, Dreyling, Martin, Martinez-Lopez, Joaquin, Kolstad, Arne, Butler, Jason, Ghosh, Monalisa, Popplewell, Leslie, Chavez, Julio C., Bachy, Emmanuel, Kato, Koji, Harigae, Hideo, Kersten, Marie José, Andreadis, Charalambos, Riedell, Peter A., Ho, P. Joy, Pérez-Simón, José Antonio, Chen, Andy I., Nastoupil, Loretta J., von Tresckow, Bastian, Ferreri, Andrés José María, Teshima, Takanori, Patten, Piers E. M., McGuirk, Joseph P., Petzer, Andreas L., Offner, Fritz, Viardot, Andreas, Zinzani, Pier Luigi, Malladi, Ram, Zia, Aiesha, Awasthi, Rakesh, Masood, Aisha, Anak, Oezlem, Schuster, Stephen J., Thieblemont, Catherine

Volltext

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087 von Chen, Robert, Zinzani, Pier Luigi, Lee, Hun Ju, Armand, Philippe, Johnson, Nathalie A., Brice, Pauline, Radford, John, Ribrag, Vincent, Molin, Daniel, Vassilakopoulos, Theodoros P., Tomita, Akihiro, von Tresckow, Bastian, Shipp, Margaret A., Lin, Jianxin, Kim, Eunhee, Nahar, Akash, Balakumaran, Arun, Moskowitz, Craig H.

Volltext